Michael M Copenhaver

Biographic Data

ID	1561096
NAME	Michael M Copenhaver
GIVEN NAMES	Michael M
FAMILY NAME	Copenhaver
SIGNATURE	COPENHAVER M M
AFFILIATIONS	University of Connecticut
VERIFIED	No
TOTAL WORKS	21
TOTAL CITATIONS	47
WORKS AS AUTHOR	21
WORKS AS EDITOR	0
FIRST PUBLICATION YEAR	2000
LATEST PUBLICATION YEAR	2026
H-INDEX	2

Depressive Symptoms and Anticipated Help-seeking Stigma as Mental Healthcare Navigation Barriers Among People Who Use Opioids
Open AccessAntoine Khati, Md Safaet Hossain Sujan et al.ARTICLECommunity Mental Health Journal2026
Non-fatal Overdose and Associated Factors Among People Who Use Opioids
Open AccessMd Safaet Hossain Sujan, Jeffrey A Wickersham et al.ARTICLEJournal of Community Health2025
Examining the Accuracy of Self-Reported Antiretroviral Therapy Adherence Using a Visual Analog Scale Among Opioid-Dependent People Living with HIV
Open AccessJude Ssenyonjo, Xiaomeng Li et al.ARTICLEAIDS and Behavior2024
Integrating Cognitive Dysfunction Accommodation Strategies Into Behavioral Interventions for Persons on Medication for Opioid Use Disorder
Open AccessColleen B Mistler, Christie I Idiong et al.ARTICLEFrontiers in Public Health2022
BACKGROUND: Cognitive dysfunction is disproportionately prevalent among persons with opioid use disorder (OUD). Specific domains of cognitive dysfunction (attention, executive functioning, memory, and information processing) may significantly impede treatment outcomes among patients on medication for OUD (MOUD). This limits patient's ability to learn, retain, and apply information conveyed in behavioral intervention sessions. Evidence-based accom…
Purposeful Fentanyl Use and Associated Factors among Opioid-Dependent People Who Inject Drugs
Divya K Chandra, Frederick L Altice et al.ARTICLESubstance Use & Misuse2021
Introduction: In recent years, opioid-related mortality has increased steadily in the United States. Fentanyl, a synthetic opioid, has been a primary driver of the current wave of overdose-related deaths. Little is known, however, about fentanyl use among opioid-dependent people who inject drugs (PWID). We, therefore, sought to characterize purposeful fentanyl use among PWID. Methods: A cross-sectional survey was administrated to 104 opioid-depen…
The Impact of Covid-19 on Access to HIV Prevention Services Among Opioid-Dependent Individuals
Open AccessColleen B Mistler, Christine M Curley et al.ARTICLEJournal of Community Health2021
Engagement in Harm Reduction Strategies After Suspected Fentanyl Contamination Among Opioid-Dependent Individuals
Open AccessColleen B Mistler, Divya K Chandra et al.ARTICLEJournal of Community Health2021
Use of Pre-exposure Prophylaxis Among People Who Inject Drugs
Open AccessXin Zhou, Frederick L Altice et al.ARTICLEAIDS and Behavior2021
Integrated Bio-behavioral Approach to Improve Adherence to Pre-exposure Prophylaxis and Reduce HIV Risk in People Who Use Drugs
Open AccessRoman Shrestha, Frederick L Altice et al.ARTICLEAIDS and Behavior2018
Association Between Intimate Partner Violence Against Women and HIV-Risk Behaviors
Open AccessRoman Shrestha, Michael M Copenhaver et al.ARTICLEViolence Against Women2016References: 2
Intimate partner violence (IPV) is a significant global health issue and has been associated with an increased HIV-related risk and vulnerability to HIV infection. This study examined the potential relationship between IPV and HIV-risk behaviors among women in Nepal. Our findings revealed that IPV against women was associated with the presence of HIV-risk behaviors, such as history of sexually transmitted infections (STIs), multiple sex partners,…
The Impact of Alcohol Use and Related Disorders on the HIV Continuum of Care: a Systematic Review
Open AccessPanagiotis Vagenas, Marwan M Azar et al.ARTICLECurrent HIV/AIDS Reports2015
Alcohol use disorders negatively influence antiretroviral medication adherence among men who have sex with men in Peru
Enrico G Ferro, Damian Weikum et al.ARTICLEAIDS Care2015
As international guidelines increase access to antiretroviral therapy (ART) globally, ART adherence becomes increasingly important to achieve HIV treatment as prevention (TasP) goals. In the concentrated HIV epidemic among men who have sex with men (MSM) and transgendered women (TGW) in Lima, Peru, the independent correlates of ART nonadherence were examined to inform treatment intervention priorities. Cross sectional survey of HIV-infected MSM a…
Intersectionality of internalized HIV stigma and internalized substance use stigma
Open AccessValerie A Earnshaw, L R Smith et al.ARTICLEJournal of Health Psychology2015Cited by: 30References: 28
We adopted an intersectionality framework and examined whether the relationship between internalized HIV stigma and depressive symptoms is moderated by internalized substance use stigma. A total of 85 people living with HIV with a history of substance use in the Bronx, New York, completed a survey. Results revealed evidence of moderation: Participants who internalized HIV stigma experienced greater depressive symptoms only if they also internaliz…
HIV Stigma Mechanisms and Well-Being Among PLWH
Open AccessValerie A Earnshaw, L R Smith et al.ARTICLEAIDS and Behavior2013
A Randomized Controlled Trial of the Community-Friendly Health Recovery Program (CHRP) Among High-Risk Drug Users in Treatment
Open AccessMichael M Copenhaver, Michael D Miller et al.ARTICLEAIDS and Behavior2013
The influence of neurocognitive impairment on HIV treatment outcomes among drug-involved people living with HIV/Aids
Ifeoma Ezeabogu, Michael M Copenhaver et al.ARTICLEAIDS Care2012
Findings to date indicate that it is feasible to deliver a brief behavioral risk reduction/medication adherence group intervention to HIV-infected injection drug users in a community-based setting. HIV infection and substance abuse can result in neurocognitive impairment and this is directly relevant to intervention development, because a significant number of people living with HIV/AIDS have a positive history of substance abuse and being able t…
Attitudes toward needle-sharing and HIV transmission risk behavior among HIV+ injection drug users in clinical care
Wynne E Norton, K Rivet Amico et al.ARTICLEAIDS Care2008
Risky behavior related to injection drug use accounts for a considerable proportion of incident HIV infection in the United States. Large numbers of injection drug users (IDUs) currently receive antiretroviral therapy in clinical settings and are accessible for risk-reduction interventions to reduce transmission of drug-resistant HIV and spread of HIV to uninfected others. The current study examined attitudes toward needle- or equipment-sharing a…
Examining the Decay of HIV Risk Reduction Outcomes Following a Community-Friendly Intervention Targeting Injection Drug Users in Treatment
Michael M Copenhaver, Michael D Miller et al.ARTICLEJournal of Psychoactive Drugs2007
It has become crucial for risk reduction interventions targeting injection drug users (IDUs) in treatment to be "community-friendly" and potent over time so that limited resources may be optimally utilized. This study examined (1) the extent to which observed post-intervention effects--including enhanced HIV-related knowledge, motivation, behavioral skills, and drug- and sex-risk reduction behavior--decayed over time and (2) whether repeating the…
Experts Outline Ways to Decrease the Decade-Long Yearly Rate of 40,000 New HIV Infections in the US
Open AccessMichael M Copenhaver, Michael D Miller et al.ARTICLEAIDS and Behavior2006
Optimizing a Community-Friendly HIV Risk Reduction Intervention for Injection Drug Users in Treatment
Open AccessMichael M Copenhaver, Michael D Miller et al.ARTICLEJournal of Urban Health2006
Masculine Gender-Role Stress, Anger, and Male Intimate Abusiveness
Open AccessMichael M Copenhaver, Michael D Miller et al.ARTICLESex Roles2000Cited by: 17References: 2